MedTrace Logo

Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis

NCT01656616 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2017-05-18

No results posted yet for this study

Summary

The costs to a rural emergency medical services (EMS) system of a change from a traditional cyanide antidote kit to a kit containing hydroxocobalamin alone are currently unknown. The purpose of this study is to use current EMS data to calculate the costs to a rural EMS system associated with the adoption of a hydroxocobalamin protocol for the treatment of suspected cyanide exposure.

Conditions

  • Cyanide Poisoning

Interventions

DRUG

Cyanide antidote administration

Sponsors & Collaborators

  • MaineHealth

    lead OTHER

Principal Investigators

  • Tania D Strout, PhD, RN, MS · MaineHealth

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-01
Primary Completion
2012-08-01
Completion
2012-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01656616 on ClinicalTrials.gov